vendredi le 25 juillet 2008 - 08:39:05 |
BourseInvestir : Portail finances et Bourse - Québec
|
Mise à jour : vendredi, 25 juillet 2008 12:00:31 Etc/ Yahoo! Finance: THR.TO News vendredi, 25 juillet 2008 12:00:31 Etc/ mercredi, 18 juin 2008 05:00:00 Etc/ ThromboGenics NV and BioInvent International AB announce that they have entered into a license agreement with Roche for their jointly developed anti-cancer agent TB-403. TB-403 is a novel monoclonal antibody which blocks Placental Growth Factor , one of the growth factors responsible for the development of new blood vessels. mardi, 17 juin 2008 12:00:27 Etc/ lundi, 9 juin 2008 12:00:19 Etc/ mardi, 3 juin 2008 06:00:00 Etc/ - vendredi, 23 mai 2008 16:59:00 Etc/ - jeudi, 15 mai 2008 20:30:00 Etc/ mercredi, 9 avril 2008 13:00:19 Etc/ TORONTO, ONTARIO-- - Thundermin Resources Inc. and 50% joint venture partner Cornerstone Resources Inc. provide the following update on the progress of the $1,000,000 exploration program, including approximately 6,200 metres of drilling, that commenced in late January on the Little Deer copper property. jeudi, 24 janvier 2008 15:34:40 Etc/ mercredi, 2 janvier 2008 15:51:01 Etc/ mardi, 11 décembre 2007 13:30:15 Etc/ jeudi, 29 novembre 2007 15:09:36 Etc/ mardi, 30 octobre 2007 20:35:06 Etc/ jeudi, 18 octobre 2007 14:28:23 Etc/ |
| |||||||||||||||||||||||||||||||